Durability of pericardial versus porcine bioprosthetic heart valves

Slides:

Advertisements

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Advertisements

Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B

Society of Thoracic Surgeons 2008 cardiac risk models predict in-hospital mortality of heart valve surgery in a Chinese population: A multicenter study

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Manuel J. Antunes, MD, PhD, DSc

A cherry blossom moment in the history of heart valve replacement

The fate of small-size pericardial heart valve prostheses in an older patient population Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Mitral stenosis with pulmonary hypertension: We should operate early

Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E

Orlando Petrucci, MD, PhD, Philip R. Khoury, MS, Peter B

Durability of bioprosthetic valves in the pulmonary position: Long-term follow-up of 181 implants in patients with congenital heart disease Cheul Lee,

YingXing Wu, MD, Ruyun Jin, MD, Guangqiang Gao, MD, Gary L

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis Evaldas Girdauskas,

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.

Ground glass opacity of the lung: The veil that needs lifting

Bayesian stopping guidelines for heart valve premarket approval studies Gary L. Grunkemeier, PhD, YingXing Wu, MD, MS, Lian Wang, MS, Cody Hamilton, PhD

Form ever follows function

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

It is still mostly about the mitral valve

Long-Term Outcomes of the Mosaic Bioprosthesis

Bicuspid aortic valve aortopathy: One size fits all?

Jennifer S. Lawton, MD, Nader Moazami, MD, Michael K

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial) Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,

The lord of the rings Antonio Miceli, MD, PhD

Actuarial versus actual risk of porcine structural valve deterioration

Management of dilated ascending aorta during aortic valve replacement: Valve replacement alone versus aorta wrapping versus aorta replacement Seung Hyun.

The variability of the mitral valve anatomy and terminology

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

Fixing the supply problem

Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years Charles A. Yankah, MD, PhD, Miralem Pasic, MD,

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Fifteen years of experience with ATS mechanical heart valve prostheses

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

A cherry blossom moment in the history of heart valve replacement

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Replicating the success of mitral valve repair in the aortic valve

Influence of experience and the surgical learning curve on long-term patient outcomes in cardiac surgery Bryan M. Burt, MD, Andrew W. ElBardissi, MD,

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: A propensity-matched analysis of 2 strategies in high-risk patients

Warfarin or aspirin after mitral valve repair: Why work harder?

Hans-Joachim Schäfers, MD

Concomitant replacement of the ascending aorta is free—for some

Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients Nicolas Amabile, MD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

Tissue valve, nitinol stent, or storage solution

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: When a choice is not an echo

Between a rock and a hard place

YingXing Wu, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Durability of pericardial versus porcine bioprosthetic heart valves Gary L. Grunkemeier, PhD, Anthony P. Furnary, MD, YingXing Wu, MD, MS, Lian Wang, MS, Albert Starr, MD The Journal of Thoracic and Cardiovascular Surgery Volume 144, Issue 6, Pages 1381-1386 (December 2012) DOI: 10.1016/j.jtcvs.2012.08.060 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Scatter plot of patient age during implant year, with local regression (LOESS; locally weighted scatterplot smoothing) nonparametric regression curves fit to the individual points. AVR, Aortic valve replacement; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 1381-1386DOI: (10.1016/j.jtcvs.2012.08.060) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Cumulative incidence function estimates of explant for any reason in operative survivors. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 1381-1386DOI: (10.1016/j.jtcvs.2012.08.060) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Cumulative incidence function estimates of explant for structural valve deterioration (SVD) in operative survivors. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 1381-1386DOI: (10.1016/j.jtcvs.2012.08.060) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Kaplan-Meier (KM) estimate of explantation, superimposed on the distribution of multiple valve states over time for the porcine and pericardial aortic valve replacement series combined. The Journal of Thoracic and Cardiovascular Surgery 2012 144, 1381-1386DOI: (10.1016/j.jtcvs.2012.08.060) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions